Athanassios Kotsinas Selected Research

Athanassios Kotsinas Research Topics

Disease

24	Neoplasms (Cancer) 10/2021 - 05/2003
6	Carcinogenesis 01/2021 - 12/2011
4	Genomic Instability 01/2021 - 10/2002
3	Infections 01/2022 - 01/2012
3	Inflammation (Inflammations) 01/2015 - 05/2012
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2012 - 10/2002
2	Breast Neoplasms (Breast Cancer) 05/2021 - 05/2003
2	Carcinoma (Carcinomatosis) 03/2011 - 07/2004
1	COVID-19 01/2022
1	Chromosome Inversion (Chromosomal Inversion) 12/2021
1	Disease Progression 10/2021
1	Premature Aging 10/2021
1	Cockayne Syndrome (Syndrome, Cockayne) 10/2021
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2017
1	Communicable Diseases (Infectious Diseases) 01/2017
1	Virus Diseases (Viral Diseases) 01/2017
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2015
1	Adenocarcinoma 07/2014
1	Myxoma (Myxomas) 01/2012
1	Neoplasm Metastasis (Metastasis) 12/2011
1	Colorectal Neoplasms (Colorectal Cancer) 01/2011
1	Atherosclerosis 09/2010
1	Hyperplasia 04/2005
1	Chromosomal Instability (Chromosome Stability) 04/2005
1	Dysplastic Nevus Syndrome (Dysplastic Nevus) 04/2005
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2005
1	Colonic Neoplasms (Colon Cancer) 09/2004

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 10/2021 - 10/2002
3	Messenger RNA (mRNA)IBA 01/2022 - 10/2002
3	Pharmaceutical PreparationsIBA 01/2020 - 11/2019
3	DNA (Deoxyribonucleic Acid)IBA 01/2012 - 10/2002
3	E2F1 Transcription FactorIBA 09/2004 - 10/2002
2	Transcription Factors (Transcription Factor)IBA 12/2021 - 07/2014
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2015
2	A-Form DNA (A-DNA)IBA 10/2021 - 04/2005
2	Biological ProductsIBA 05/2021 - 12/2014
2	MicroRNAs (MicroRNA)IBA 01/2015 - 12/2014
2	Phosphotransferases (Kinase)IBA 08/2013 - 03/2011
2	ParaffinIBA 05/2012 - 01/2012
2	ErbB Receptors (EGF Receptor)IBA 05/2012 - 01/2011
2	Formaldehyde (Formol)FDA Link 05/2012 - 01/2012
1	CytokinesIBA 01/2022
1	ApolipoproteinsIBA 01/2022
1	EnzymesIBA 01/2022
1	IgA receptor (protein B)IBA 10/2021
1	Polymethyl Methacrylate (Sol)IBA 05/2021
1	titanium dioxide (Titania)FDA Link 05/2021
1	SilverIBA 05/2021
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2021
1	UbiquitinIBA 12/2019
1	Ligases (Synthetase)IBA 12/2019
1	NucleotidesIBA 01/2018
1	Beclin-1IBA 09/2017
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 09/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017
1	NLR ProteinsIBA 01/2017
1	VaccinesIBA 01/2017
1	MutagensIBA 01/2015
1	CarcinogensIBA 01/2015
1	E2F Transcription FactorsIBA 08/2014
1	Cell Adhesion MoleculesIBA 10/2012
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 10/2012
1	Free RadicalsIBA 05/2012
1	Cadherins (E-Cadherin)IBA 12/2011
1	AntibodiesIBA 01/2011
1	LDL Lipoproteins (beta Lipoproteins)IBA 09/2010
1	oxidized low density lipoproteinIBA 09/2010
1	ProteomeIBA 07/2009
1	3' Untranslated Regions (3' UTR)IBA 02/2008
1	IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)IBA 02/2008
1	Histones (Histone)IBA 04/2005
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2005
1	Carrier Proteins (Binding Protein)IBA 04/2005
1	Toll-Like Receptor 4IBA 02/2005
1	fas Receptor (CD95 Antigen)IBA 05/2003
1	Protein Isoforms (Isoforms)IBA 05/2003
1	LigandsIBA 05/2003
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 10/2002

Therapy/Procedure

4	Therapeutics 12/2019 - 12/2008
1	Radiotherapy 01/2015
1	Investigational Therapies (Experimental Therapy) 07/2009